KIYATEC Receives Breast Cancer Research Funding


SCRA Technology Ventures’ SC Launch recently announced that its portfolio company KIYATEC has received a National Cancer Institute Phase I SBIR (Small Business Innovation Research) contract, which includes a $295,000 award.

KIYATEC will use the award to establish three-dimensional breast cancer models using living cells obtained directly from breast cancer patients. These models will be used to screen anticancer drugs during pre-clinical development and allows for testing patient-derived samples in real time to assist clinical decision-making. The National Cancer Institute is one of the 27 institutes and centers that comprise the National Institutes of Health.

KIYATEC was selected as a main presenter at the 15th Anniversary Southeast BIO Investor & Partnering Forum earlier in November. The event is the Southeast region’s premier life sciences and medical technology conference, connecting emerging companies with potential investors and partners in a forum that provides meaningful networking opportunities.



Related Articles

Related Posts